High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission.

Autor: Stein, A S, O’Donnell, M R, Slovak, M L, Nademanee, A, Dagis, A, Schmidt, G M, Parker, P M, Snyder, D S, Smith, E P, Somlo, G, Margolin, K A, Arber, D, Niland, J, Forman, S J, O'Donnell, M R (AUTHOR)
Zdroj: Leukemia (08876924). Jul2000, Vol. 14 Issue 7, p1191-1196. 6p.
Databáze: Academic Search Ultimate